Effects of the?-glucosidase inhibitor 1 desoxynojirimycin (BAY M 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients-Reference-Cited by-同舟云学术

Effects of the?-glucosidase inhibitor 1 desoxynojirimycin (BAY M 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients

Published:1986 Issue:4 Volume:30 Page:417-419
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Schnack Ch.,R�ggla G.,Luger A.,Schernthaner G.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00607953.pdf

Reference5 articles.

1. Puls W, Keup U, Krause HP, Thomas G, Hoffmeister F (1977) Glucosidase inhibition ? a new approach to the treatment of diabetes, obesity and hyperlipoproteinaemia. Naturwissenschaften 64: 536?537

2. Creutzfeld W (1982) Proceedings of the First International Symposium on Acarbose, Montreux 1981, Amsterdam, Excerpta Medica

3. Schmidt DD, Frommer W, Jung B, Müller L, Wingender W, Truscheit E, Schäfer D (1977)?-glucosidase inhibitors. New complex of oligosaccharides of microbial origin. Naturwissenschaften 64: 535?536

4. Schmidt DD, Frommer W, Müller L, Truscheit E (1979) Glucosidase-Inhibitoren aus Bazillen. Naturwissenschaften 66: 584?585

5. Hillebrand I, Boehme K, Graefe KH, Wehling K, Fink H (1984) Effect of two new glucosidase inhibitors (Bay m 1099 and Bay O 1248) on post-prandial blood glucose and serum insulin levels in normal subjects. Diabetologia 27: 288 A

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. α-Glucosidase immobilization on functionalized Fe3O4 magnetic nanoparticles for screening of enzyme inhibitors;Chinese Chemical Letters;2019-03

2. Design and Synthesis of Labystegines, Hybrid Iminosugars from LAB and Calystegine, as Inhibitors of Intestinal α-Glucosidases: Binding Conformation and Interaction for ntSI;The Journal of Organic Chemistry;2015-04-13

3. Administration of miglitol until 30min after the start of a meal is effective in type 2 diabetic patients;Diabetes Research and Clinical Practice;2007-10

4. Divided-Dose Administration of Miglitol just before and 15 Minutes after the Start of a Meal Smoothes Postprandial Plasma Glucose Excursions and Serum Insulin Responses in Healthy Men;Endocrine Journal;2007

5. Back to (non)-Basics: Recent Developments in Neutral and Charge- Balanced Glycosidase Inhibitors;Mini-Reviews in Medicinal Chemistry;2003-11-01